An early backer of Moderna Therapeutics on the core investing lesson behind a big coronavirus bet

A venture capitalist and former Gates Foundation investor, who years ago backed Covid-19 vaccine contender Moderna Therapeutics, weighs in on how to think about investing during the coronavirus pandemic.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.